GXO deploys first AI-driven autonomous truck at French warehouse

GXO Logistics Inc. (NYSE: GXO) has deployed its first autonomous industrial truck powered by artificial intelligence at its facility in Épinoy, France. The contract logistics provider announced the pilot program represents collaboration between KION, NVIDIA and Accenture to integrate AI-driven material handling technology into warehouse operations.

The autonomous truck pilot aims to demonstrate improvements in cost-savings, productivity, operational scalability and safety in a high-volume warehouse environment. GXO is operating the pilot as part of testing advanced automation capabilities in live logistics operations.

"As we integrate advanced AI into our operations, our priority is creating real, measurable impact," said GXO CEO Patrick Kelleher. "Exploring autonomous capabilities in live warehouse pilots is part of how we continue to innovate and build an increasingly intelligent and resilient supply chain."

The pilot represents a milestone in the strategic collaboration between industrial truck provider KION, NVIDIA and Accenture to bring AI innovation, digital twins and perception technology from laboratory settings to commercial supply chain operations. GXO's warehouse serves as the testing environment where these technologies transition from simulation to commercial deployment.

GXO CEO Patrick Kelleher and KION Group CEO Rob Smith are scheduled to participate in a panel discussion at NVIDIA's GTC 2026 Conference in San Jose on March 18 at 9:00 a.m. PT. The discussion will focus on AI's role in transforming global supply chains and highlight GXO's position as the pilot site for KION's NVIDIA-powered Physical AI technology.

GXO operates over 150,000 team members across more than 1,000 facilities totaling over 200 million square feet. The company is based in Greenwich, Connecticut.

You May Also Be Interested In

• Alphabet added to Dow Jones Industrial Average, Verizon dropped
• ConAgra Brands board member Chirico to step down at annual meeting
• Enanta Pharma loses appeal in Pfizer Paxlovid patent case